Insufflator, laparoscopic The ConMed GS2000, Smith & Nephew 500, Novadaq 50L and Nebulae I ins...

FDA Device Recall #Z-0866-2017 — Class II — November 21, 2016

Recall Summary

Recall Number Z-0866-2017
Classification Class II — Moderate risk
Date Initiated November 21, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Northgate Technologies, Inc.
Location Elgin, IL
Product Type Devices
Quantity 49 devices

Product Description

Insufflator, laparoscopic The ConMed GS2000, Smith & Nephew 500, Novadaq 50L and Nebulae I insufflators are devices that provide CO2 gas distention of surgical cavities for diagnostic and/or operative endoscopy. The insufflator has multiple operating modes which can be used for the following procedures: General Laparoscopic, Pediatric Laparoscopic, Bariatric Laparoscopic and Minimally Invasive Vessel Harvesting procedures

Reason for Recall

Device could cause a patient overpressure situation without any visual or auditory indication or warning

Distribution Pattern

Worldwide Distribution - US including FL and MA. Internationally to Canada

Lot / Code Information

Serial Numbers: #89170HXB, #89556DYD, #89652FYA, #89661FYA, #89663FYA, #89664FYA, #89670FYA, #89672FYA, #89675FYA, #89677FYA, #89685FYB, #89697FYB, #89708GYA, #89713GYA, #89719GYB, #89720GYB, #89729GYB, #89732GYB, #89734GYB, #89737GYB, #89889IYD, #90165AZB, #90285BZD, #90387DZB, #90391DZB, #90415DZD, #90438DZD, #90469EZB, #90528EZD, #90555FZB, #90556FZB, #90557FZB, #90558FZB, #90561FZB, #90583GZC, #90621GZB, #90654HZB, #90739IZD, #90869KZD, #90931LZD, #90936LZD, #90954LZD, #90962LZD, #90972LZD, #91105CAD, #91108CAD, #91114CAD, #91120CAD, #91380FAC, #91406FAD, #91471GAC, #91544IAC

Other Recalls from Northgate Technologies, Inc.

Recall # Classification Product Date
Z-1235-2022 Class II AUTOLITH Touch 1.9F 375cm Biliary Electrohydrau... Apr 13, 2022
Z-0333-2022 Class II Boston Scientific AUTOLITH TOUCH Bipolar Electr... Oct 25, 2021
Z-1148-2021 Class II Steris CO2MPACT Endoscopic Insufflator system, ... Jan 15, 2021
Z-1147-2021 Class II ConMed 50L abdominal insufflator, Catalog Numbe... Jan 15, 2021
Z-1883-2020 Class II Probe, 9 FR AUTOLITH; NTI Catalog Number 9-900-... Mar 10, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.